Medical Treatment to increase sperm count, motility and quality
You are here : Home >> Services >> MALE SERVICES >> Medical Treatment to increase sperm count, motility and quality
Anti-oxidants and vitamins that improves sperm count and motility and quality:
Approximately, 30-80% of male infertility cases is caused by oxidative stress and decreased level of seminal total antioxidant capacity. Oxidative stress occurs when the production of reactive oxygen species exceeds the body’s natural antioxidant defenses. The increased level of reactive oxygen species can be resulted from environmental factors such as high temperature, electromagnetic waves, air pollution, insecticides, alcohol consumption, obesity and poor nutrition. There is evidence that sperm is simply affected by reactive oxygen species and oxidative stress. Reactive oxygen species production pathologically results in high levels of DNA damage.
In most studies, antioxidant supplementation improved the number, motility, morphology and sometimes the DNA integrity of sperm. These antioxidants neutralize free radical activity and protect sperm from reactive oxygen species that are already produced.
A combination of antioxidant multivitamins such as L-carnitine, Co Q10, Vitamin C, Vitamin E, Zinc, Folic acid, N-acetyl cysteine, Alpha-tocopherol, Superoxide dismutase, Glutathione, Thioredoxin, Biotin, Astaxanthin, L – Arginine, Cobalamin, Ethyl cysteine, Inositol, Lycopene, Magnesium, Pentoxifylline, Vitamin D, Alpha lipoic acid, and Selenium improve male fertility by improving sperm count and sperm mobility and sperm morphology.
The administration of oral antioxidant supplements improves semen parameters such as sperm count, motility, morphology, DNA damage, and fertility rate.
The normal standard values of semen analysis by the World Health Organization:
Standard values of sperm parameters are as follow: PH equal or greater than 7.2, semen concentration equal or greater than 15 million per milliliter, and semen volume 1.5 ml or higher, sperm progressive motility of 32% or higher and normal morphology equal or more than 4%.